Showing results (31-40 of 142) with videos related to

Sort By:
Pageof 15
Cancer Immunology Research|January 29, 2016
Synergistic COX2 Induction by IFNγ and TNFα Self-Limits Type-1 Immunity in the Human Tumor MicroenvironmentJeffrey L Wong, Nataša Obermajer, Kunle Odunsi, et al.
Journal of Leukocyte Biology|April 23, 2008
Type 1-polarized dendritic cells loaded with autologous tumor are a potent immunogen against chronic lymphocytic leukemiaJe-Jung Lee, Kenneth A Foon, Robbie B Mailliard, et al.
Immunologic Research|March 6, 2007
Helper roles of NK and CD8+ T cells in the induction of tumor immunity. Polarized dendritic cells as cancer vaccinesPawel Kalinski, Yutaro Nakamura, Payal Watchmaker, et al.
Journal of Virology|December 17, 2008
Reevaluating the CD8 T-cell response to herpes simplex virus type 1: involvement of CD8 T cells reactive to subdominant epitopesBrian S Sheridan, Thomas L Cherpes, Julie Urban, et al.
Oncoimmunology|May 4, 2016
CXCL11-Armed oncolytic poxvirus elicits potent antitumor immunity and shows enhanced therapeutic efficacyZuqiang Liu, Roshni Ravindranathan, Jun Li, et al.
Immunological Investigations|September 29, 2012
PGE(2)-driven induction and maintenance of cancer-associated myeloid-derived suppressor cellsNataša Obermajer, Jeffrey L Wong, Robert P Edwards, et al.
Neoplasia (New York, N.Y.)|January 12, 2013
Expression of CCL19 from oncolytic vaccinia enhances immunotherapeutic potential while maintaining oncolytic activityJun Li, Mark O'Malley, Padma Sampath, et al.
Cancer Research|July 18, 2008
Ability of mature dendritic cells to interact with regulatory T cells is imprinted during maturationRavikumar Muthuswamy, Julie Urban, Je-Jung Lee, et al.
Pageof 15